RMD ResMed, Inc.

132.18-3.86 (-2.84%)
Close: August 23, 2019

Quote

Previous Close
$132.18
Day Range
$131.35-$136.19
52 Week Range
$90.64-$137.38
Volume
529,521
Avg Volume
530,608
Dividend TTM
$1.48 (1.12%)
Ex-Dividend Date
2019-08-14

Valuation

Market Cap
$18.99B
Enterprise Value (EV)
$20.67B
PE Ratio
46.79
EV/EBITDA
26.27
Price/Sales
7.50
Price/Book
9.16
PEG Ratio
-

Financials

Revenue
$2.61B
Gross Profit
$1.46B
EBITDA
$786.78M
EPS, ttm
$2.83
Profit Margin
15.52%
Revenue/Employee
$360.02K
Next Earnings Date
10/24/2019 (60 days)
Debt to Equity
61%
Debt
$1.83B
Cash
$147.13M
Net Debt
$1.68B

Performance

Beta
0.84
200 Day Moving Avg
$111.41
50 Day Moving Avg
$126.42
52 Week Change
21.38%
YTD Change
15.42%
1 Month Change
5.36%
3 Month Change
16.06%
6 Month Change
30.02%
1 Year Change
21.38%
2 Year Change
64.30%
5 Year Change
125.40%

Share Count

Shares Outstanding
143.7M
Float
142.4M
Restricted Shares
1.3M
Restricted Shares, %
0.89%

ResMed, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Michael J. Farrell

Website: http://www.resmed.com

Description: ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Employees: 7,240